FOXP3 and neoplasm: Patients who achieved pCR were found to have a significantly lower density of FoxP3+ cells, which was consistent with previous reports that neoadjuvant chemotherapy increased cytotoxic T Cell, and B cell infiltration and decreased the density of Foxp3+ T cells (23) in the tumor of resectable NSCLC patients (21, 22).